Epigenetic Multiple Ligands: Mixed Histone/Protein Methyltransferase, Acetyltransferase, and Class III Deacetylase (Sirtuin) Inhibitors-Reference-Cited by-同舟云学术

Epigenetic Multiple Ligands: Mixed Histone/Protein Methyltransferase, Acetyltransferase, and Class III Deacetylase (Sirtuin) Inhibitors

Published:2008-03-19 Issue:7 Volume:51 Page:2279-2290
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Mai Antonello¹,Cheng Donghang¹,Bedford Mark T.¹,Valente Sergio¹,Nebbioso Angela¹,Perrone Andrea¹,Brosch Gerald¹,Sbardella Gianluca¹,De Bellis Floriana¹,Miceli Marco¹,Altucci Lucia¹

Affiliation:

1. Istituto Pasteur - Fondazione Cenci Bolognetti, Dipartimento di Studi Farmaceutici, Università degli Studi di Roma “La Sapienza”, P.le A. Moro 5, 00185 Roma, Italy, The University of Texas M.D. Anderson Cancer Center, Science Park-Research Division, Smithville, Texas 78957, Dipartimento di Patologia Generale, Seconda Università degli Studi di Napoli, vico L. De Crecchio 7, 80138 Napoli, Italy, Division of Molecular Biology, Biocenter, Innsbruck Medical University, Fritz-Preglstrasse 3, 6020 Innsbruck,...

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm701595q

Reference86 articles.

1. Epigenetic therapy of cancer: past, present and future

2. Cancer epigenetics

3. Epigenetics in human disease and prospects for epigenetic therapy

4. Epigenetics—An Epicenter of Gene Regulation: Histones and Histone-Modifying Enzymes

5. Protein–nucleic acid interactions: from A(rgonaute) to X(PF)

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a Protein Arginine Methyltransferase 7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) Inhibitor;Journal of Medicinal Chemistry;2023-08-10

2. Metabolites and Immune Response in Tumor Microenvironments;Cancers;2023-07-31

3. Unraveling the complexity of histone-arginine methyltransferase CARM1 in cancer: From underlying mechanisms to targeted therapeutics;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-07

4. Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction–Reconstruction and Fragment-Growing Approach;Journal of Medicinal Chemistry;2022-04-28

5. Remodeling the Epigenetic Landscape of Cancer—Application Potential of Flavonoids in the Prevention and Treatment of Cancer;Frontiers in Oncology;2021-06-21